Across treatment groups, in-hospital mortality was numerically highest in the patients who received empirical teicoplanin (57.89%) versus the linezolid group (42.57%) and the vancomycin group (35.82%), but this difference did not reach statistical significance ( p = 0.121).
← all excerpts
Clinical outcomes of empirical anti-MRSA therapy at a tertiary care center in Madinah, Saudi Arabia: a retrospective single-center cohort study.
1
0.1210
0.1210